l-NAME prevents GM1 ganglioside-induced vasodilation in the rat brain

Neurochemistry International

Volumn 53, Issue 6-8, 2008, Pages 362-369

  Furian, Ana Flávia ^a,b   Oliveira, Mauro Schneider ^a,b   Magni, Danieli Valnes ^a   Souza, Mauren Assis ^a   Bortoluzzi, Vanessa Trindade ^a   Bueno, Lívia Maronesi ^a   Royes, Luiz Fernando Freire ^a   Mello, Carlos Fernando ^a  

^a FEDERAL UNIVERSITY OF SANTA MARIA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Cortex; GM1 ganglioside; Hippocampus; l NAME; Neuroprotection; Rat

Indexed keywords

MONOSIALOGANGLIOSIDE; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRITE; VASODILATOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; BRAIN CORTEX; CONTROLLED STUDY; HEMOGLOBIN BLOOD LEVEL; MALE; NONHUMAN; OUTCOME ASSESSMENT; PIA ARTERY; PRIORITY JOURNAL; RAT; VASODILATATION;

ANIMALS; ARTERIOLES; BRAIN; CEREBRAL ARTERIES; CEREBROVASCULAR CIRCULATION; ENZYME INHIBITORS; G(M1) GANGLIOSIDE; MALE; MICROCIRCULATION; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; NITRITES; ORGAN CULTURE TECHNIQUES; RATS; RATS, WISTAR; VASODILATION;

ANIMALIA; RATTUS;

EID: 56349156088     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2008.07.011     Document Type: Article

References (75)

1. Adachi N., Lei B., Soutani M., and Arai T. Different roles of neuronal and endothelial nitric oxide synthases on ischemic nitric oxide production in gerbil striatum. Neurosci. Lett. 288 (2000) 151-154
2. Assreuy J., Cunha F.Q., Liew F.Y., and Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br. J. Pharmacol. 108 (1993) 833-837
3. Avrova N.F., Tyurin V.A., Tyurina Y., and Kagan V.E. Gangliosides in postischemic cellular dysfunctions. Ann. NY Acad. Sci. 723 (1994) 353-355
4. Avrova N.F., Victorov I.V., Tyurin V.A., Zakharova I.O., Sokolova T.V., Andreeva N.A., Stelmaschuk E.V., Tyurina Y.Y., and Gonchar V.S. Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochem. Res. 23 (1998) 945-952
5. Avrova N.F., Shestak K.I., Zakharova I.O., Sokolova T.V., Tyurina Y.Y., and Tyurin V.A. The use of antioxidants to prevent glutamate-induced derangement of calcium ion metabolism in rat cerebral cortex synaptosomes. Neurosci. Behav. Physiol. 30 (2000) 535-541
6. Baek R.C., Kasperzyk J.L., Platt F.M., and Seyfried T.N. N-Butyldeoxygalactonojirimycin reduces brain ganglioside and GM2 content in neonatal Sandhoff disease mice. Neurochem. Int. 52 (2008) 1125-1133
7. Baumgartner W.A., Redmond M., Brock M., Tseng E., Blue M.E., Troncoso J.C., and Johnston M.V. Pathophysiology of cerebral injury and future management. J. Card. Surg. 12 (1997) 300-311 (discussion 310-301)
8. Bemeur C., Ste-Marie L., and Montgomery J. Increased oxidative stress during hyperglycemic cerebral ischemia. Neurochem. Int. 50 (2007) 890-904
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
10. Bryan N.S., and Grisham M.B. Methods to detect nitric oxide and its metabolites in biological samples. Free Radic. Biol. Med. 43 (2007) 645-657
11. Calabrese V., Mancuso C., Calvani M., Rizzarelli E., Butterfield D.A., and Stella A.M. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8 (2007) 766-775
12. Canabal D.D., Potian J.G., Duran R.G., McArdle J.J., and Routh V.H. Hyperglycemia impairs glucose and insulin regulation of nitric oxide production in glucose-inhibited neurons in the ventromedial hypothalamus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 293 (2007) R592-R600
13. Carolei A., Fieschi C., Bruno R., and Toffano G. Monosialoganglioside GM1 in cerebral ischemia. Cerebrovasc. Brain Metab. Rev. 3 (1991) 134-157
14. Chen Z.G., Lu Y.C., Zhu C., Zhang G.J., Ding X.H., and Jiang J.Y. Effects of ganglioside GM1 on reduction of brain edema and amelioration of cerebral metabolism after traumatic brain injury. Chin. J. Traumatol. 6 (2003) 23-27
15. Colasanti M., Persichini T., Fabrizi C., Cavalieri E., Venturini G., Ascenzi P., Lauro G.M., and Suzuki H. Expression of a NOS-III-like protein in human astroglial cell culture. Biochem. Biophys. Res. Commun. 252 (1998) 552-555
16. Dawson T.M., Hung K., Dawson V.L., Steiner J.P., and Snyder S.H. Neuroprotective effects of gangliosides may involve inhibition of nitric oxide synthase. Ann. Neurol. 37 (1995) 115-118
17. Dimmeler S., Assmus B., Hermann C., Haendeler J., and Zeiher A.M. Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis. Circ. Res. 83 (1998) 334-341
18. Duchemin A.M., Neff N.H., and Hadjiconstantinou M. GM1 increases the content and mRNA of NGF in the brain of aged rats. Neuroreport 8 (1997) 3823-3827
19. Duchemin A.M., Neff N.H., and Hadjiconstantinou M. Induction of Trk phosphorylation in rat brain by GM1 ganglioside. Ann. NY Acad. Sci. 845 (1998) 406
20. Duchemin A.M., Ren Q., Mo L., Neff N.H., and Hadjiconstantinou M. GM1 ganglioside induces phosphorylation and activation of Trk and Erk in brain. J. Neurochem. 81 (2002) 696-707
21. Duchemin A.M., Ren Q., Neff N.H., and Hadjiconstantinou M. GM1-induced activation of phosphatidylinositol 3-kinase: involvement of Trk receptors. J. Neurochem. (2007)
22. Fighera M.R., Bonini J.S., de Oliveira T.G., Frussa-Filho R., Rocha J.B., Dutra-Filho C.S., Rubin M.A., and Mello C.F. GM1 ganglioside attenuates convulsions and thiobarbituric acid reactive substances production induced by the intrastriatal injection of methylmalonic acid. Int. J. Biochem. Cell Biol. 35 (2003) 465-473
23. Fighera M.R., Bonini J.S., Frussa-Filho R., Dutra-Filho C.S., Hagen M.E., Rubin M.A., and Mello C.F. Monosialoganglioside increases catalase activity in cerebral cortex of rats. Free Radic. Res. 38 (2004) 495-500
24. +-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiol. Dis. 22 (2006) 611-623
25. Fong T.G., Neff N.H., and Hadjiconstantinou M. GM1 ganglioside improves spatial learning and memory of aged rats. Behav. Brain Res. 85 (1997) 203-211
26. Fulton D., Gratton J.P., McCabe T.J., Fontana J., Fujio Y., Walsh K., Franke T.F., Papapetropoulos A., and Sessa W.C. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 399 (1999) 597-601
27. Furchgott R.F., and Vanhoutte P.M. Endothelium-derived relaxing and contracting factors. FASEB J. 3 (1989) 2007-2018
28. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
29. Furian A.F., Oliveira M.S., Royes L.F., Fiorenza N.G., Fighera M.R., Myskiw J.C., Weiblen R., Rubin M.A., Frussa-Filho R., and Mello C.F. GM1 ganglioside induces vasodilation and increases catalase content in the brain. Free Radic. Biol. Med. 43 (2007) 924-932
30. Goettl V.M., Zhang H., Burrows A.C., Wemlinger T.A., Neff N.H., and Hadjiconstantinou M. GM1 enhances dopaminergic markers in the brain of aged rats. Exp. Neurol. 183 (2003) 665-672
31. Gorria M., Huc L., Sergent O., Rebillard A., Gaboriau F., Dimanche-Boitrel M.T., and Lagadic-Gossmann D. Protective effect of monosialoganglioside GM1 against chemically induced apoptosis through targeting of mitochondrial function and iron transport. Biochem. Pharmacol. 72 (2006) 1343-1353
32. Henry J. Clinical Diagnosis and Management by Laboratory Methods (1991), W.B. Saunders Co., Philadelphia
33. Higashi H., and Yamagata T. Mechanism for ganglioside-mediated modulation of a calmodulin-dependent enzyme. Modulation of calmodulin-dependent cyclic nucleotide phosphodiesterase activity through binding of gangliosides to calmodulin and the enzyme. J. Biol. Chem. 267 (1992) 9839-9843
34. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., and Moskowitz M.A. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-l-arginine. J. Cereb. Blood Flow Metab. 16 (1996) 981-987
35. Katsuki S., Arnold W., Mittal C., and Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J. Cyclic Nucleotide Res. 3 (1977) 23-35
36. Kavya R., Saluja R., Singh S., and Dikshit M. Nitric oxide synthase regulation and diversity: implications in Parkinson's disease. Nitric Oxide 15 (2006) 280-294
37. Kumura E., Kosaka H., Shiga T., Yoshimine T., and Hayakawa T. Elevation of plasma nitric oxide end products during focal cerebral ischemia and reperfusion in the rat. J. Cereb. Blood Flow Metab. 14 (1994) 487-491
38. Kwak D.H., Kim S.M., Lee D.H., Kim J.S., Kim S.M., Lee S.U., Jung K.Y., Seo B.B., and Choo Y.K. Differential expression patterns of gangliosides in the ischemic cerebral cortex produced by middle cerebral artery occlusion. Mol. Cells 20 (2005) 354-360
39. Ledeen R.W., and Yu R.K. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83 (1982) 139-191
40. Lee T.J. Nitric oxide and the cerebral vascular function. J. Biomed. Sci. 7 (2000) 16-26
41. Marsden P.A., Heng H.H., Scherer S.W., Stewart R.J., Hall A.V., Shi X.M., Tsui L.C., and Schappert K.T. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J. Biol. Chem. 268 (1993) 17478-17488
42. Miranda K.M., Espey M.G., and Wink D.A. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5 (2001) 62-71
43. Mo L., Ren Q., Duchemin A.M., Neff N.H., and Hadjiconstantinou M. GM1 and ERK signaling in the aged brain. Brain Res. 1054 (2005) 125-134
44. Moncada S., and Higgs E.A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest. 21 (1991) 361-374
45. Morikawa E., Rosenblatt S., and Moskowitz M.A. l-Arginine dilates rat pial arterioles by nitric oxide-dependent mechanisms and increases blood flow during focal cerebral ischaemia. Br. J. Pharmacol. 107 (1992) 905-907
46. Morikawa E., Moskowitz M.A., Huang Z., Yoshida T., Irikura K., and Dalkara T. l-Arginine infusion promotes nitric oxide-dependent vasodilation, increases regional cerebral blood flow, and reduces infarction volume in the rat. Stroke 25 (1994) 429-435
47. Nozaki K., Moskowitz M.A., Maynard K.I., Koketsu N., Dawson T.M., Bredt D.S., and Snyder S.H. Possible origins and distribution of immunoreactive nitric oxide synthase-containing nerve fibers in cerebral arteries. J. Cereb. Blood Flow Metab. 13 (1993) 70-79
48. 2+ channels in cultured human astrocytes. Glia 46 (2004) 53-62
49. Palmer R.M., Ferrige A.G., and Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327 (1987) 524-526
50. Perry J.C., Vital M.A., Frussa-Filho R., Tufik S., and Palermo-Neto J. Monosialoganglioside (GM1) attenuates the behavioural effects of long-term haloperidol administration in supersensitive rats. Eur. Neuropsychopharmacol. 14 (2004) 127-133
51. Podoprigora G.I., Nartsissov Y.R., and Aleksandrov P.N. Effect of glycine on microcirculation in pial vessels of rat brain. Bull. Exp. Biol. Med. 139 (2005) 675-677
52. Rabin S.J., Bachis A., and Mocchetti I. Gangliosides activate Trk receptors by inducing the release of neurotrophins. J. Biol. Chem. 277 (2002) 49466-49472
53. Rahmann H. Brain gangliosides and memory formation. Behav. Brain Res. 66 (1995) 105-116
54. Riboni L., and Tettamanti G. Rapid internalization and intracellular metabolic processing of exogenous ganglioside by cerebellar granule cells differentiated in culture. J. Neurochem. 57 (1991) 1931-1939
55. Rodrigo J., Springall D.R., Uttenthal O., Bentura M.L., Abadia-Molina F., Riveros-Moreno V., Martinez-Murillo R., Polak J.M., and Moncada S. Localization of nitric oxide synthase in the adult rat brain. Philos. Trans. R. Soc. Lond. B Biol. Sci. 345 (1994) 175-221
56. Rothblat D.S., and Schneider J.S. Spontaneous functional recovery from Parkinsonism is not due to reinnervation of the dorsal striatum by residual dopaminergic neurons. Brain Res. Bull. 34 (1994) 309-312
57. Schengrund C.L. The role(s) of gangliosides in neural differentiation and repair: a perspective. Brain Res. Bull. 24 (1990) 131-141
58. Schneider J.S. GM1 ganglioside in the treatment of Parkinson's disease. Ann. NY Acad. Sci. 845 (1998) 363-373
59. Silva R.H., Felicio L.F., Nasello A.G., Vital M.A., and Frussa-Filho R. Effect of ganglioside (GM1) on memory in senescent rats. Neurobiol. Aging 17 (1996) 583-586
60. Skaper S.D., Facci L., and Leon A. Gangliosides attenuate the delayed neurotoxicity of aspartic acid in vitro. Neurosci. Lett. 117 (1990) 154-159
61. Sobey C.G., and Quan L. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage. Am. J. Physiol. 277 (1999) H1718-1724
62. Svennerholm L. Gangliosides-a new therapeutic agent against stroke and Alzheimer's disease. Life Sci. 55 (1994) 2125-2134
63. Svennerholm L., Brane G., Karlsson I., Lekman A., Ramstrom I., and Wikkelso C. Alzheimer disease-effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme. Dement Geriatr. Cogn. Disord. 14 (2002) 128-136
64. Takeo C., Nakamura S., Tanaka T., Uchida D., Noguchi Y., Nagao T., Saito Y., and Tatsuno I. Rat cerebral endothelial cells express trk C and are regulated by neurotrophin-3. Biochem. Biophys. Res. Commun. 305 (2003) 400-406
65. Tan W.K., Williams C.E., Gunn A.J., Mallard E.C., and Gluckman P.D. Pretreatment with monosialoganglioside GM1 protects the brain of fetal sheep against hypoxic-ischemic injury without causing systemic compromise. Pediatr Res. 34 (1993) 18-22
66. Tanaka K., Dora E., Urbanics R., Greenberg J.H., Toffano G., and Reivich M. Effect of the ganglioside GM1, on cerebral metabolism, microcirculation, recovery kinetics of ECoG and histology, during the recovery period following focal ischemia in cats. Stroke 17 (1986) 1170-1178
67. Tettamanti G. Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj. J. 20 (2004) 301-317
68. Thomas B., Saravanan K.S., and Mohanakumar K.P. In vitro and in vivo evidences that antioxidant action contributes to the neuroprotective effects of the neuronal nitric oxide synthase and monoamine oxidase-B inhibitor, 7-nitroindazole. Neurochem. Int. 52 (2008) 990-1001
69. Tseng E.E., Brock M.V., Lange M.S., Troncoso J.C., Blue M.E., Lowenstein C.J., Johnston M.V., and Baumgartner W.A. Monosialoganglioside GM1 inhibits neurotoxicity after hypothermic circulatory arrest. Surgery 124 (1998) 298-306
70. Vallance P., Collier J., and Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 2 (1989) 997-1000
71. Vincent S.R., and Kimura H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience 46 (1992) 755-784
72. Wieraszko A., and Seifert W. The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices. Brain Res. 345 (1985) 159-164
73. Wu G., Lu Z.H., Wang J., Wang Y., Xie X., Meyenhofer M.F., and Ledeen R.W. Enhanced susceptibility to kainate-induced seizures, neuronal apoptosis, and death in mice lacking gangliotetraose gangliosides: protection with LIGA, 20 a membrane-permeant analog of GM1. J. Neurosci. 25 (2005) 11014-11022
74. Yanagisawa K. Role of gangliosides in Alzheimer's disease. Biochim. Biophys. Acta 1768 (2007) 1943-1951
75. Zeller C.B., and Marchase R.B. Gangliosides as modulators of cell function. Am. J. Physiol. 262 (1992) C1341-1355